WeVote
Log In

Bill

Bill

SB 121

An Act relating to the Board of Pharmacy; relating to insurance; relating to pharmacies; relating to pharmacists; relating to pharmacy benefits managers; relating to patient choice of pharmacy; and providing for an effective date.

33rd Legislature (2023-2024) Introduced by Jesse Bjorkman and 5 co-sponsors

Alaska bill regulating pharmacy benefit managers and insurance to expand patient pharmacy choice and potentially limit PBM restrictions on pharmacies and pharmacist services.

(S) COSPONSOR(S): CLAMAN
#boards&commissions #business #consumeraffairs #contracts #crimes #drugs #fees #hearings #hospitals #insurance #medicalcare #pharmacists #rights #tradepractices
0
WeVote Research Nonpartisan
Bill Summary · SB 121

Legislative bill overview

SB 121 is an Alaska bill addressing pharmacy operations, insurance coverage, and the relationship between pharmacists, pharmacies, and pharmacy benefits managers (PBMs). The bill appears to focus on patient choice of pharmacy and regulating PBM practices, though specific provisions aren't detailed in the available information.

Why is this important

Pharmacy benefit managers control which pharmacies patients can use and what they pay, often creating conflicts between patient access and corporate profits. This bill could affect healthcare costs, pharmacy viability in rural areas, and patients' ability to choose their preferred pharmacist—issues that impact both individual healthcare autonomy and Alaska's pharmacy infrastructure.

Potential points of contention

  • PBM regulation scope: Defining how much authority the state has to regulate PBMs, which often operate under federal oversight and national networks
  • Insurance cost implications: Changes to PBM practices could increase or decrease insurance premiums depending on implementation
  • Pharmacy network impacts: Mandating broader patient choice could strain smaller or rural pharmacies financially, or conversely, protect them from restrictive PBM networks
  • Board of Pharmacy authority: Expanding the Board's regulatory role may create oversight questions and administrative costs

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.